iShares MSCI China (MCHI) Rises 0.87% for Sep 17

September 17, 2017 - By Adrian Erickson

Sep 17 is a positive day so far for iShares MSCI China (NASDAQ:MCHI) as the ETF is active during the day after gaining 0.87% to hit $63.65 per share. The exchange traded fund has 2.58B net assets and 1.12% volatility this month.

Over the course of the day 3.06 million shares traded hands, as compared to an average volume of 1.58M over the last 30 days for iShares MSCI China (NASDAQ:MCHI).

The ETF is -9.35% of its 52-Week High and 28.38% of its low, and is currently having ATR of 0.8. This year’s performance is 1.48% while this quarter’s performance is -4.43%.

The ETF’s YTD performance is 0%, the 1 year is 0% and the 3 year is 0%.

More notable recent iShares MSCI China Index Fund (NASDAQ:MCHI) news were published by: Marketwatch.com which released: “This China-focused fund beats its rivals by looking beyond Alibaba and Tencent” on September 06, 2017, also Etfdailynews.com with their article: “Chinese Stocks Just Broke Through Major Resistance (MCHI)” published on August 29, 2017, Cnbc.com published: “MSCI’s big decision on adding mainland China stocks to emerging markets index” on June 19, 2017. More interesting news about iShares MSCI China Index Fund (NASDAQ:MCHI) were released by: Forbes.com and their article: “What Are The Odds For China’s A-Shares Getting The MSCI Greenlight?” published on April 06, 2017 as well as Investorplace.com‘s news article titled: “3 Red-Hot Chinese ETFs That Deserve More Attention” with publication date: August 30, 2017.

iShares MSCI China ETF, formerly iShares MSCI China Index Fund , is an exchange traded fund. The company has market cap of $2.58 billion. The Fund seeks investment results that correspond to the price and yield performance, of the MSCI China Index (the Underlying Index). It currently has negative earnings. The Fund is designed to measure the performance of the top 85% of equity securities by market capitalization in the Chinese equity markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.